Literature DB >> 35593019

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination.

Lauren C Shapiro1, Astha Thakkar1, Radhika Gali1, Jesus D Gonzalez-Lugo1, Abdul-Hamid Bazarbachi2, Shafia Rahman1, Kith Pradhan1, Karen Fehn1, Michelly Abreu1, Noah Kornblum1, Kira Gritsman1, Mendel Goldfinger1, Aditi Shastri1, Ioannis Mantzaris1, Ira Braunschweig1, Balazs Halmos1, Amit Verma1, Margaret McCort3, Lizamarie Bachier-Rodriguez1, R Alejandro Sica1.   

Abstract

Entities:  

Keywords:  COVID-19 vaccination; hematologic malignancies; minorities

Mesh：

Substances：

Year:  2022        PMID： 35593019     DOI： 10.1080/10428194.2022.2074988

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies.

Authors:  Maryam Noori; Shadi Azizi; Farhan Abbasi Varaki; Seyed Aria Nejadghaderi; Davood Bashash
Journal:  Int Immunopharmacol       Date:  2022-07-12       Impact factor: 5.714

2.  COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis.

Authors:  Yusuke Ito; Akira Honda; Mineo Kurokawa
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2022-03-28

3.  Impaired serological response to COVID-19 vaccination following anticancer therapy: A systematic review and meta-analysis.

Authors:  Kefu Tang; Zhiying Wei; Xi Wu
Journal:  J Med Virol       Date:  2022-07-06       Impact factor: 20.693
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.